United States · FDA National Drug Code directory
IMKELDI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81927-201_dead98c8-2ac0-4fe6-890a-cc8c92ddcffc
- Product NDC
- 81927-201
- Form
- SOLUTION
- Composition / generic term
- imatinib oral
- Labeler
- Shorla Oncology Inc.,
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241219
- Source listing expiry
- 20261231
Source-listed ingredients
- IMATINIB MESYLATE — 80 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 140 mL in 1 BOTTLE (81927-201-01) · 81927-201-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →